ES2471403T3 - Utilización de precursores de taquicininas y/o de sus fragmentos en diagnóstico m�dico - Google Patents

Utilización de precursores de taquicininas y/o de sus fragmentos en diagnóstico m�dico Download PDF

Info

Publication number
ES2471403T3
ES2471403T3 ES05747755.6T ES05747755T ES2471403T3 ES 2471403 T3 ES2471403 T3 ES 2471403T3 ES 05747755 T ES05747755 T ES 05747755T ES 2471403 T3 ES2471403 T3 ES 2471403T3
Authority
ES
Spain
Prior art keywords
protaquicinin
sec
antibody
disease
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05747755.6T
Other languages
English (en)
Spanish (es)
Inventor
Andreas Bergmann
Andrea Ernst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sphingotec GmbH
Original Assignee
Sphingotec GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sphingotec GmbH filed Critical Sphingotec GmbH
Application granted granted Critical
Publication of ES2471403T3 publication Critical patent/ES2471403T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
    • G01N2410/06—Kallidins; Bradykinins; Related peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES05747755.6T 2004-04-20 2005-04-20 Utilización de precursores de taquicininas y/o de sus fragmentos en diagnóstico m�dico Expired - Lifetime ES2471403T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04009284 2004-04-20
EP04009284 2004-04-20
PCT/EP2005/004254 WO2005103712A2 (en) 2004-04-20 2005-04-20 Use of precursors of tachykinins and/or their fragments in medical diagnostic

Publications (1)

Publication Number Publication Date
ES2471403T3 true ES2471403T3 (es) 2014-06-26

Family

ID=34924661

Family Applications (2)

Application Number Title Priority Date Filing Date
ES05747755.6T Expired - Lifetime ES2471403T3 (es) 2004-04-20 2005-04-20 Utilización de precursores de taquicininas y/o de sus fragmentos en diagnóstico m�dico
ES11165586.6T Expired - Lifetime ES2524309T3 (es) 2004-04-20 2005-04-20 Utilización de precursores de taquicininas y/o de sus fragmentos en diagnóstico médico

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES11165586.6T Expired - Lifetime ES2524309T3 (es) 2004-04-20 2005-04-20 Utilización de precursores de taquicininas y/o de sus fragmentos en diagnóstico médico

Country Status (5)

Country Link
US (2) US7838245B2 (enExample)
EP (3) EP2518510A1 (enExample)
JP (2) JP5095391B2 (enExample)
ES (2) ES2471403T3 (enExample)
WO (1) WO2005103712A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5095391B2 (ja) 2004-04-20 2012-12-12 スフィンゴテック・ゲーエムベーハー 医療診断におけるタキキニンの前駆体および／またはその断片の使用
JP2009092550A (ja) * 2007-10-10 2009-04-30 Japan Health Science Foundation うつ病またはうつ状態の同定方法
SG10201704689XA (en) 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
SG10201505723UA (en) 2010-07-23 2015-09-29 Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
MX2013000917A (es) 2010-07-23 2013-07-05 Harvard College Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
AU2011334548B2 (en) * 2010-11-26 2016-06-09 Immunexpress Pty Ltd Diagnostic and/or screening agents and uses therefor
EA201590024A1 (ru) 2012-06-15 2015-05-29 Гарри Стилли Способы определения заболеваний или состояний с применением циркулирующих болезненных клеток
CN104603289A (zh) 2012-06-15 2015-05-06 哈里·斯泰利 检测疾病或病状的方法
CN109116025A (zh) * 2013-01-08 2019-01-01 斯弗因高泰克有限公司 预测受试者患癌症的风险或诊断癌症的方法
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
TR201905773T4 (tr) * 2013-10-01 2019-05-21 Sphingotec Gmbh Bir majör advers kardiyak olayla karşılaşma riskinin tahmin edilmesi için bir usul.
EP4428251A3 (en) 2014-09-11 2024-12-18 Immunis.AI, Inc. Methods of detecting prostate cancer
US20240272178A1 (en) * 2021-06-18 2024-08-15 Sphingotec Gmbh A method for predicting sepsis and septic shock

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613431D0 (en) * 1986-06-03 1986-07-09 Medical Res Council Human tachykinins
US5434050A (en) * 1991-08-13 1995-07-18 Regents Of The University Of Minnesota Labelled β-amyloid peptide and methods of screening for Alzheimer's disease
JPH082798B2 (ja) * 1991-12-13 1996-01-17 日本全薬工業株式会社 抗体を利用した新しいタイプの鎮痛薬
KR100430960B1 (ko) * 1995-05-11 2004-10-28 거번먼트오브더유나이티드스테이츠오브아메리카,애즈리프리젠티드바이더세크러트리오브디아미 매우약독화된재조합일본뇌염바이러스를생성하는감염성일본뇌염바이러스cDNA클론및이의백신
GB9606736D0 (en) * 1996-02-19 1996-06-05 Shire International Licensing Therapeutic method
CA2744096C (en) * 1996-07-31 2013-07-30 Laboratory Corporation Of America Holdings Biomarkers and targets for diagnosis, prognosis and management of prostate disease
CA2190679A1 (en) * 1996-11-19 1998-05-19 Christopher J. Paige Lymphocyte tachykinin
US6372440B2 (en) * 1999-03-10 2002-04-16 Magnesium Diagnostics, Inc. Method for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses
AU765753B2 (en) * 1999-05-17 2003-09-25 Conjuchem Biotechnologies Inc. Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
AU1057001A (en) * 1999-11-08 2001-06-06 Suntory Limited Novel physiologically active peptides and process for producing the same
CA2395714A1 (en) * 1999-12-21 2001-06-28 Takeda Chemical Industries, Ltd. Novel tachykinin-like polypeptides and use thereof
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
US7425217B2 (en) * 2000-11-16 2008-09-16 Maier Nathan C System and method for inhibiting cellular proliferation with tachykinins
JP2004536581A (ja) * 2001-04-18 2004-12-09 ジェンセット ソシエテ アノニム 分泌される可能性のあるタンパク質をコードする全長ヒトｃＤＮＡ
CA2445261A1 (en) * 2001-05-01 2002-12-27 Geneprot, Inc. Human tachykinin-related splice variants and compositions thereof
AU2002326769A1 (en) * 2001-08-24 2003-03-10 Incyte Genomics, Inc. Extracellular messengers
WO2003025547A1 (en) * 2001-09-21 2003-03-27 Biomedlab Corporation Method and device for screening analytes using surface plasmon resonance
US20030114763A1 (en) * 2001-12-13 2003-06-19 Reddy Shankara B. Fusion of computerized medical data
AU2003278002A1 (en) * 2002-10-03 2004-04-23 Mcgill Univeristy Antibodies and cyclic peptides which bind cea (carcinoembryonic antigen) and their use as cancer therapeutics
WO2004076614A2 (de) 2003-02-27 2004-09-10 Bernd Hinzmann Humane nukleinsäuresequenzen aus prostatakarzinomen
WO2005043111A2 (en) * 2003-07-14 2005-05-12 Ciphergen Biosystems, Inc. Serum biomarkers for sars
JP5095391B2 (ja) 2004-04-20 2012-12-12 スフィンゴテック・ゲーエムベーハー 医療診断におけるタキキニンの前駆体および／またはその断片の使用

Also Published As

Publication number Publication date
WO2005103712A2 (en) 2005-11-03
JP2012112978A (ja) 2012-06-14
US9188591B2 (en) 2015-11-17
JP5095391B2 (ja) 2012-12-12
ES2524309T3 (es) 2014-12-05
EP2369350A3 (en) 2012-01-25
US20080260640A1 (en) 2008-10-23
US20110275091A1 (en) 2011-11-10
EP2369350B1 (en) 2014-08-20
EP2518510A1 (en) 2012-10-31
US7838245B2 (en) 2010-11-23
EP2369350A2 (en) 2011-09-28
WO2005103712A3 (en) 2006-12-14
JP5607094B2 (ja) 2014-10-15
JP2007533985A (ja) 2007-11-22
EP1740957B1 (en) 2014-03-12
EP1740957A2 (en) 2007-01-10

Similar Documents

Publication Publication Date Title
JP5607094B2 (ja) 医療診断におけるタキキニンの前駆体および／またはその断片の使用
ES2431288T3 (es) Uso de precursores de encefalinas y/o sus fragmentos en diagnosis médica
Rouillon et al. Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy
Chutipongtanate et al. Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor
Inder et al. Expression of PTRF in PC-3 Cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways
US20160193203A1 (en) Treatment of peritoneal injury using jak inhibitors
JP2023065484A (ja) 新規タウ種
CN104694478A (zh) 抗人脂联素的单克隆抗体及其应用
US8592223B2 (en) Use of periostin as a novel biomarker
Janssens et al. On methods for the measurement of the apelin receptor ligand apelin
Nielsen et al. Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers
JP2004532633A (ja) 進行性の慢性痴呆疾患の検出方法、これに適したペプチド及び検出試薬
ES2734124T3 (es) Identificación de propiedades de unión de anticuerpos reactivos con un miembro de la familia de los receptores de la insulina
US20150037816A1 (en) PCSK9 Function Assay
KR102320436B1 (ko) 교모종줄기세포 엑소좀 유래 펩타이드를 포함하는 교모세포종의 진단용 바이오마커 조성물
Zhang et al. Expression, purification and identification of isotope-labeled recombinant cystatin C protein in Escheichia coli intended for absolute quantification using isotope dilution mass spectrometry
Šimetić et al. Laboratory use of hepcidin in renal transplant recipients
JPWO2020085458A1 (ja) 哺乳動物の嗅粘膜または嗅粘液の検査方法
US20260002943A1 (en) Biomarkers for diagnosing equine asthma
Deep et al. Journal of Biological and Chemical Research
JP2025082445A (ja) 活性型ｉｌ－１８検出キット、及び検査方法
HK40065091A (en) A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction in pediatric patients
Tienari et al. Ezrin Is Down-Regulated in Diabetic Kidney Glomeruli and Regulates Actin Reorganization and Glucose Uptake via GLUT1 in Cultured Podocytes